HOUSTON, Texas, November 1st, 2023 -- Mercury Data Science (MDS), a pioneering AI solutions consultancy specializing in life sciences, is thrilled to announce the appointment of Michael Bell, Ph.D., as the company's Vice President of Platforms.
HOUSTON, Texas, October 2023 -- Mercury Data Science (MDS), an AI solutions consultancy focused on life sciences, announces that the company has appointed Robyn Cardwell as the company's Chief Growth Officer.
Artificial intelligence has great potential to transform clinical trials by enhancing retention, aiding in participant recruitment, personalizing engagement, detecting dropout risk, predicting intervention strategies, and monitoring adverse events to improve benefiting participants, sites, and sponsors – all at reduced costs.
In this post we explore digital biomarkers, their advantages and challenges, and use cases for life science companies that want to maintain their competitive edge and lead innovation.
In recent times, the buzz surrounding ChatGPT, a powerful language model, has captured everyone's imagination. While use cases continue to surface for many industries, the potential for Life Sciences remains to be fully explored. The field of Life Sciences presents a unique and complex landscape with its own set of opportunities.
Mercury Data Science + Janssen abstract publication at the American College of Neuropsychopharmacology 61st Annual Meeting.
Trying to extract usable insights from the world’s biomedical knowledge can be like trying to escape from a black hole - how can we unlock the potential?
Many organizations have valuable unstructured data that they fail to use - learn how NLP can extract hidden meaning, uncover relationships, and improve predictive ML models.
HOUSTON, Texas, July 12 -- Mercury Data Science (MDS), an AI solutions consultancy focused on life sciences and healthcare, announces that the company has appointed Angela Holmes as the company's Chief Executive Officer.